Frontier Biotechnologies Inc.

Quick facts

Phase 2 pipeline

• AB001 · Oncology
  AB001 is a small molecule that targets the PD-1 receptor.
• Baseline ART · Infectious Diseases
  Baseline ART works by suppressing the replication of the human immunodeficiency virus (HIV) through the inhibition of reverse transcriptase.

Phase 1 pipeline

• FB2001 for inhalation
• positive comparative patch

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Frontier Biotechnologies Inc. portfolio CI brief
• Frontier Biotechnologies Inc. pipeline updates RSS